التفاصيل البيبلوغرافية
| العنوان: |
Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer. |
| المؤلفون: |
Antonio, Maite, Saldaña, Juana, Linares, Jennifer, Ruffinelli, José C, Palmero, Ramón, Navarro, Arturo, Arnaiz, Maria Dolores, Brao, Isabel, Aso, Samantha, Padrones, Susana, Navarro, Valentí, González-Barboteo, Jesús, Borràs, Josep Maria, Cardenal, Felipe, Nadal, Ernest, Saldaña, Juana, Ruffinelli, José C, Palmero, Ramón, Navarro, Valentí, González-Barboteo, Jesús |
| المصدر: |
British Journal of Cancer; 3/6/2018, Vol. 118 Issue 5, p639-647, 9p, 1 Diagram, 4 Charts, 1 Graph |
| مصطلحات موضوعية: |
LUNG cancer treatment, PLATINUM, TREATMENT of lung tumors, GERIATRIC assessment, COMPARATIVE studies, CONSENSUS (Social sciences), DECISION making, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, PALLIATIVE treatment, RESEARCH, SURVIVAL analysis (Biometry), EVALUATION research, TREATMENT effectiveness, THERAPEUTICS |
| مصطلحات جغرافية: |
SPAIN |
| مستخلص: |
Background: Although concurrent chemoradiotherapy (cCRT) increases survival in patients with inoperable, locally advanced non-small-cell lung cancer (NSCLC), there is no consensus on the treatment of elderly patients. The aim of this study was to determine the prognostic value of the comprehensive geriatric assessment (CGA) and its ability to predict toxicity in this setting.Methods: We enrolled 85 consecutive elderly (⩾75 years) participants, who underwent CGA and the Vulnerable Elders Survey (VES-13). Those classified as fit and medium-fit by CGA were deemed candidates for cCRT (platinum-based chemotherapy concurrent with thoracic radiation therapy), while unfit patients received best supportive care.Results: Fit (37%) and medium-fit (48%) patients had significantly longer median overall survival (mOS) (23.9 and 16.9 months, respectively) than unfit patients (15%) (9.3 months, log-rank P=0.01). In multivariate analysis, CGA groups and VES-13 were independent prognostic factors. Fit and medium-fit patients receiving cCRT (n=54) had mOS of 21.1 months (95% confidence interval: 16.2, 26.0). In those patients, higher VES-13 (⩾3) was associated with shorter mOS (16.33 vs 24.3 months, P=0.027) and higher risk of G3-4 toxicity (65 vs 32%, P=0.028).Conclusions: Comprehensive geriatric assessment and VES-13 showed independent prognostic value. Comprehensive geriatric assessment may help to identify elderly patients fit enough to be treated with cCRT. [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder